Skip to content
DraconiticResearch
Search Sources API
184,584 studies31 sourcesUpdated 56 min ago
Peer-reviewedCC BYScientific Reports

Molecular targeting of DNA metabolism by brown algae metabolites in Mycobacterium chelonae: computational analysis via DFT and MD simulations

  1. 1Department of Pharmacognosy, College of Pharmacy, King Saud University

Abstract

Mycobacterium chelonae, a member of the rapidly growing mycobacteria, has been linked to a variety of infections, including skin and soft tissue infections, pulmonary disease, and disseminated infections in immunocompromised people. The limited efficacy of current treatments, as well as the emergence of drug resistance, emphasize the need for novel therapeutic interventions. The XTP pyrophosphatase protein is required for M. chelonae survival and proliferation. Its involvement in fundamental cellular processes underscores its potential as a drug target. The Glide tool was employed to dock a library of Phaeophyceae metabolites containing 1200 compounds against the XTP pyrophosphatase protein. Ten highly promising compounds were chosen for further investigation based on their binding affinities. These compounds’ binding affinity ranged from − 7.662 to -6.7 kcal/mol. Only one compound CMNPD27817 showed its expected values to be within an acceptable range after the toxicity risks and ADMET features of the selected compounds were assessed. Docking findings were supported by molecular dynamics simulation. Density functional theory (DFT) analysis further confirmed the electronic stability and favorable charge-transfer properties of CMNPD27817, supporting its potential to form stable interactions with the XTP pyrophosphatase active site. MD simulations indicated that the compound remained associated with the protein binding region over the simulated trajectory. Binding is dW-dominated and the ligand fits well into a hydrophobic binding pocket. This research could lead to the discovery of novel inhibitors of the XTP pyrophosphatase protein, unlocking the development of novel and effective therapeutic agents against M. chelonae.

Related

  1. Computational network pharmacology and molecular simulations to explore the potential mechanisms of Pyrrosia piloselloides compounds against prostate cancer.
    Husnul Havid, Ysrafil Ysrafil, Fatmaria Fatmaria +3
    Journal of the Egyptian National Cancer InstitutePeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
  2. Pharmacological regulation of chondrocyte ferroptosis by plant-derived metabolites in osteoarthritis: from molecular mechanisms to targeted nanodelivery
    Tianci Guo, Qi Liu, Jida Wang +4
    Frontiers in pharmacologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMCCrossref
  3. LC‐MS‐Based Annotation of Bioactive Metabolites From Streptomyces fimicarius‐ghR Against the Common Scab Pathogen Using Molecular Networking
    Maryam Ramezani‐Moghadam, Sareh Baghaee‐Ravari, Abolghasem Danesh +4
    Chemistry & BiodiversityPeer-reviewedCC BY-NC-ND 4.0Full textPharmacology & toxicologyPMC
  4. Wildlife as a Potential Reservoir of Paratuberculosis: Molecular Evidence of Mycobacterium avium Subspecies paratuberculosis in a Biosphere Reserve, the Sudan.
    Enass M Abdalla, Omer M Meina, Sanaa M Idris +12
    Animals : an open access journal from MDPIPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
  5. Substrate Comprising Fibrosis and Epicardial Adipose Tissue-Associated Electrophysiological Remodeling Can Sustain Atrial Fibrillation Drivers: Insights from Image-Personalized Computational Simulations
    Yaacoub Chahine, Heather Wood, Åshild Telle +9
    Heart rhythmPeer-reviewedCC BYFull textCardiovascular medicinePMC
BibTeX
@article{alanzi2026molecular,
  title = {{Molecular targeting of DNA metabolism by brown algae metabolites in Mycobacterium chelonae: computational analysis via DFT and MD simulations}},
  author = {Abdullah R. Alanzi and Hattan A. Alharbi and Jawaher H. Alqahtani},
  journal = {Scientific Reports},
  year = {2026},
  month = sep,
  doi = {10.1038/s41598-026-71167-0},
  url = {https://doi.org/10.1038/s41598-026-71167-0},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Molecular targeting of DNA metabolism by brown algae metabolites in Mycobacterium chelonae: computational analysis via DFT and MD simulations
AU  - Abdullah R. Alanzi
AU  - Hattan A. Alharbi
AU  - Jawaher H. Alqahtani
PY  - 2026
DA  - 2026/09/01
JO  - Scientific Reports
DO  - 10.1038/s41598-026-71167-0
UR  - https://doi.org/10.1038/s41598-026-71167-0
AB  - Mycobacterium chelonae, a member of the rapidly growing mycobacteria, has been linked to a variety of infections, including skin and soft tissue infections, pulmonary disease, and disseminated infections in immunocompromised people. The limited efficacy of current treatments, as well as the emergence of drug resistance, emphasize the need for novel therapeutic interventions. The XTP pyrophosphatase protein is required for M. chelonae survival and proliferation. Its involvement in fundamental cellular processes underscores its potential as a drug target. The Glide tool was employed to dock a library of Phaeophyceae metabolites containing 1200 compounds against the XTP pyrophosphatase protein. Ten highly promising compounds were chosen for further investigation based on their binding affinities. These compounds’ binding affinity ranged from − 7.662 to -6.7 kcal/mol. Only one compound CMNPD27817 showed its expected values to be within an acceptable range after the toxicity risks and ADMET features of the selected compounds were assessed. Docking findings were supported by molecular dynamics simulation. Density functional theory (DFT) analysis further confirmed the electronic stability and favorable charge-transfer properties of CMNPD27817, supporting its potential to form stable interactions with the XTP pyrophosphatase active site. MD simulations indicated that the compound remained associated with the protein binding region over the simulated trajectory. Binding is dW-dominated and the ligand fits well into a hydrophobic binding pocket. This research could lead to the discovery of novel inhibitors of the XTP pyrophosphatase protein, unlocking the development of novel and effective therapeutic agents against M. chelonae.
SN  - 2045-2322
ER  -